Medexus Announces 10% NCIB to Strengthen Shareholder Value
Toronto, Ontario & Chicago, Illinois — November 20, 2025 — Medexus Pharmaceuticals Inc. has announced that the Toronto Stock...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Mergers & Acquisitions for New Therapy
Toronto, Ontario & Chicago, Illinois — November 20, 2025 — Medexus Pharmaceuticals Inc. has announced that the Toronto Stock...
Vancouver, British Columbia — November 20, 2025 — PreveCeutical Medical Inc. has issued a formal clarification regarding its earlier...
Dateline Introduction San Diego, CA & Toronto, Canada — November 19, 2025 — Aptose Biosciences Inc. has entered into...
NEW YORK, NY — November 14, 2025 — Pfizer announced it has completed its acquisition of Metsera, Inc., strengthening...
BRISBANE, CA – November 13, 2025 — Day One Biopharmaceuticals announced a definitive agreement to acquire Mersana Therapeutics in...
Mill Valley, CA – November 10, 2025 — Four Corners Property Trust (FCPT), a real-estate investment trust specialising in...
NEW YORK and VIENNA – October 31, 2025 — HOOKIPA Pharma Inc. (OTC: HOOK) announced the completion of the...
New York, October 30, 2025 — Pfizer Inc. (NYSE: PFE) has issued a strong response to what it calls...
BOSTON, October 29, 2025 — Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology leader in RNA medicines, has...
Basel, Switzerland – October 30, 2025 — Roche Holding AG (SIX: RO, ROG; OTCQX: RHHBY) has successfully completed its...
